FRSE

Macomics Expands in Edinburgh with Move to Roslin Innovation Centre and Announces Appointment of Professor Paul Crocker to SAB

Retrieved on: 
Friday, September 29, 2023
SAB, University, Cancer, United States Air Force Scientific Advisory Board, Research, Tams, University of Dundee, Laboratory, FRSE, Drug discovery, R, University of Edinburgh, Pharmaceutical industry, Vaccine, Macrophage, MACOM Technology Solutions

The company has also announced the appointment of Professor Paul Crocker, FRSE, Emeritus Professor of Glycoimmunology, University of Dundee, to its Scientific Advisory Board (SAB).

Key Points: 
  • The company has also announced the appointment of Professor Paul Crocker, FRSE, Emeritus Professor of Glycoimmunology, University of Dundee, to its Scientific Advisory Board (SAB).
  • Macomics’ operations are located in Edinburgh and Cambridge, two major hubs of life science research in the UK with R&D teams split 50:50 across both sites.
  • To accommodate expansion and to be co-located in an entrepreneurial centre of scientific excellence, Macomics has recently moved to dedicated laboratories in the Roslin Innovation Centre.
  • Maximising on local expertise and connections, Professor Paul Crocker, FRSE, Emeritus Professor of Glycoimmunology, University of Dundee has joined Macomics’ SAB.

Gdańsk to host EuroSkills 2023

Retrieved on: 
Monday, June 20, 2022
Transport and Logistics Centre, Vocational education, Exhibition, Swedish Exhibition and Congress Centre, FRSE, City, Information and communications technology, Cooking, Information, Informal economy, Partnership, Bachelor of Engineering, Movement, Competition, Olympic Games, WorldSkills, Transport, Tourism

GDASK, Poland, June 20, 2022 /PRNewswire/ -- On June 16, during the WorldSkills Europe General Assembly held in Krakw, the City of Gdask was appointed the host of the EuroSkills Competition 2023.

Key Points: 
  • GDASK, Poland, June 20, 2022 /PRNewswire/ -- On June 16, during the WorldSkills Europe General Assembly held in Krakw, the City of Gdask was appointed the host of the EuroSkills Competition 2023.
  • More than 600 skilled young professionals from 31 countries will participate in competitions and host presentation events in 45-50 different skills at EuroSkills Gdask 2023.
  • EuroSkills Gdask 2023 will take place from 6-8 September 2023 at the AMBEREXPO Exhibition and Congress Centre (ul.
  • Gdask will also host this year's SkillsPoland 2022 competition, which serves as a pre-selection for Polish champions to take part in the EuroSkills Competition 2023.

Gdańsk to host EuroSkills 2023

Retrieved on: 
Monday, June 20, 2022
Transport and Logistics Centre, Vocational education, Exhibition, Swedish Exhibition and Congress Centre, FRSE, City, Information and communications technology, Cooking, Information, Informal economy, Partnership, Bachelor of Engineering, Movement, Competition, Olympic Games, WorldSkills, Transport, Tourism

GDASK, Poland, June 20, 2022 /PRNewswire/ -- On June 16, during the WorldSkills Europe General Assembly held in Krakw, the City of Gdask was appointed the host of the EuroSkills Competition 2023.

Key Points: 
  • GDASK, Poland, June 20, 2022 /PRNewswire/ -- On June 16, during the WorldSkills Europe General Assembly held in Krakw, the City of Gdask was appointed the host of the EuroSkills Competition 2023.
  • More than 600 skilled young professionals from 31 countries will participate in competitions and host presentation events in 45-50 different skills at EuroSkills Gdask 2023.
  • EuroSkills Gdask 2023 will take place from 6-8 September 2023 at the AMBEREXPO Exhibition and Congress Centre (ul.
  • Gdask will also host this year's SkillsPoland 2022 competition, which serves as a pre-selection for Polish champions to take part in the EuroSkills Competition 2023.

NovaBiotics to Present at the H.C. Wainwright BioConnect Conference

Retrieved on: 
Tuesday, January 4, 2022
Doctor of Philosophy, Technology, OBE, Company, Conference, FRSE, Pharmaceutical industry

ABERDEEN, Scotland, Jan. 4, 2022 /PRNewswire/ -- NovaBiotics Ltd, a privately held clinical stage company developing novel immune based therapies for life-threatening and life-limiting-diseases, today announced that Deborah O'Neil, PhD, OBE, FRSE, Chief Executive Officer of NovaBiotics, will present a company overview at the H.C. Wainwright BioConnect Conference, being held virtually, January 10-13, 2022.

Key Points: 
  • ABERDEEN, Scotland, Jan. 4, 2022 /PRNewswire/ -- NovaBiotics Ltd, a privately held clinical stage company developing novel immune based therapies for life-threatening and life-limiting-diseases, today announced that Deborah O'Neil, PhD, OBE, FRSE, Chief Executive Officer of NovaBiotics, will present a company overview at the H.C. Wainwright BioConnect Conference, being held virtually, January 10-13, 2022.
  • The on-demand presentation will be available beginning January 10, at 7:00am ET on the "Events" section of NovaBiotics' website at: https://novabiotics.co.uk/category/events/ and will be archived for a period of 90 days after the conference.
  • NovaBiotics Ltd is a privately held, clinical-stage biotechnology company revolutionizing the treatment of medically unmet, life-threatening and life-limiting diseases with novel, immune-based therapies.
  • For further information please contact:

NovaBiotics to Present at the H.C. Wainwright BioConnect Conference

Retrieved on: 
Tuesday, January 4, 2022
Doctor of Philosophy, Technology, OBE, Company, Conference, FRSE, Pharmaceutical industry

ABERDEEN, Scotland, Jan. 4, 2022 /PRNewswire/ -- NovaBiotics Ltd, a privately held clinical stage company developing novel immune based therapies for life-threatening and life-limiting-diseases, today announced that Deborah O'Neil, PhD, OBE, FRSE, Chief Executive Officer of NovaBiotics, will present a company overview at the H.C. Wainwright BioConnect Conference, being held virtually, January 10-13, 2022.

Key Points: 
  • ABERDEEN, Scotland, Jan. 4, 2022 /PRNewswire/ -- NovaBiotics Ltd, a privately held clinical stage company developing novel immune based therapies for life-threatening and life-limiting-diseases, today announced that Deborah O'Neil, PhD, OBE, FRSE, Chief Executive Officer of NovaBiotics, will present a company overview at the H.C. Wainwright BioConnect Conference, being held virtually, January 10-13, 2022.
  • The on-demand presentation will be available beginning January 10, at 7:00am ET on the "Events" section of NovaBiotics' website at: https://novabiotics.co.uk/category/events/ and will be archived for a period of 90 days after the conference.
  • NovaBiotics Ltd is a privately held, clinical-stage biotechnology company revolutionizing the treatment of medically unmet, life-threatening and life-limiting diseases with novel, immune-based therapies.
  • For further information please contact:

Recognizing and Celebrating Outstanding Contributions to the Canadian Cancer Research Community

Retrieved on: 
Monday, November 8, 2021
Linda, Quality of life, FRSE, Efficiency, Ovarian cancer, University, Lists of Padma Bhushan award recipients, Science, ISCB Senior Scientist Award, Leadership, Fortis Healthcare, Partnership, University of British Columbia, Health Canada, Organization, CEO, Disease, Doctor of Philosophy, Department, Women of Outstanding Achievement Photographic Exhibition, Terry Fox Laboratory, Alliance, Canadian Partnership Against Cancer, CCRA, Federation, Oncology nursing, Distinguished Service to Music Medal, Ovarian Cancer Research Alliance, University Health Network, CCRC, Woman, Medical genetics, Strategy, Conference, Biomedical engineering, FRSL, Princess Margaret Cancer Centre, Applied science, FRSC, Patient, School, Colorectal cancer, BC Cancer Agency, Pharmaceutical industry, Dentistry, Dietary supplement

TORONTO, Nov. 8, 2021 /CNW/ -Today, on the opening day of the sixth Canadian Cancer Research Conference (CCRC), the Canadian Cancer Research Alliance (CCRA) will announce the recipients of its biennial awards, recognizing significant contributions to cancer research in Canada.

Key Points: 
  • TORONTO, Nov. 8, 2021 /CNW/ -Today, on the opening day of the sixth Canadian Cancer Research Conference (CCRC), the Canadian Cancer Research Alliance (CCRA) will announce the recipients of its biennial awards, recognizing significant contributions to cancer research in Canada.
  • Initiated in 2011, the CCRA Awards acknowledge and celebrate the contributions of individuals who have had a remarkable impact on cancer research and the cancer research community as well as those who have shown exceptional leadership in patient involvement in cancer research.
  • Elisabeth Baugh, Chair of World Ovarian Cancer Coalition and past CEO of Ovarian Cancer Canada is the recipient of Distinguished Service to Cancer Research award for her leadership as CEO of Ovarian Cancer Canada.
  • TheCanadian Cancer Research Alliance(CCRA) is an alliance of organizations that collectively fund most of the cancer research conducted inCanada research that will lead to better ways to prevent, diagnose and treat cancer, and improve patient and survivor outcomes.